JPWO2020097446A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020097446A5 JPWO2020097446A5 JP2021523494A JP2021523494A JPWO2020097446A5 JP WO2020097446 A5 JPWO2020097446 A5 JP WO2020097446A5 JP 2021523494 A JP2021523494 A JP 2021523494A JP 2021523494 A JP2021523494 A JP 2021523494A JP WO2020097446 A5 JPWO2020097446 A5 JP WO2020097446A5
- Authority
- JP
- Japan
- Prior art keywords
- animal
- gastrointestinal barrier
- oligosaccharide preparation
- synthetic oligosaccharide
- permeability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 15
- 229920001542 oligosaccharide Polymers 0.000 claims 13
- 150000002482 oligosaccharides Chemical class 0.000 claims 13
- 230000002496 gastric effect Effects 0.000 claims 12
- 230000035699 permeability Effects 0.000 claims 8
- 230000004888 barrier function Effects 0.000 claims 7
- 239000000203 mixture Substances 0.000 claims 7
- 235000016709 nutrition Nutrition 0.000 claims 7
- 230000005549 barrier dysfunction Effects 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 4
- 210000002865 immune cell Anatomy 0.000 claims 3
- 102000004127 Cytokines Human genes 0.000 claims 2
- 108090000695 Cytokines Proteins 0.000 claims 2
- 239000008280 blood Substances 0.000 claims 2
- 210000004369 blood Anatomy 0.000 claims 2
- 230000002550 fecal effect Effects 0.000 claims 2
- 238000004949 mass spectrometry Methods 0.000 claims 2
- 238000006116 polymerization reaction Methods 0.000 claims 2
- 230000000770 proinflammatory effect Effects 0.000 claims 2
- 210000002700 urine Anatomy 0.000 claims 2
- 230000001668 ameliorated effect Effects 0.000 claims 1
- 230000001404 mediated effect Effects 0.000 claims 1
- 244000005700 microbiome Species 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023211209A JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862757500P | 2018-11-08 | 2018-11-08 | |
| US201862757465P | 2018-11-08 | 2018-11-08 | |
| US62/757,465 | 2018-11-08 | ||
| US62/757,500 | 2018-11-08 | ||
| PCT/US2019/060443 WO2020097446A1 (en) | 2018-11-08 | 2019-11-08 | Methods of supporting gastrointestinal homeostasis |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211209A Division JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022506272A JP2022506272A (ja) | 2022-01-17 |
| JP2022506272A5 JP2022506272A5 (https=) | 2022-08-23 |
| JPWO2020097446A5 true JPWO2020097446A5 (https=) | 2022-08-23 |
| JP7426548B2 JP7426548B2 (ja) | 2024-02-02 |
Family
ID=70612501
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021523494A Active JP7426548B2 (ja) | 2018-11-08 | 2019-11-08 | 胃腸の恒常性を支持する方法 |
| JP2023211209A Active JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023211209A Active JP7699647B2 (ja) | 2018-11-08 | 2023-12-14 | 胃腸の恒常性を支持する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12251391B2 (https=) |
| EP (2) | EP4162808A1 (https=) |
| JP (2) | JP7426548B2 (https=) |
| KR (2) | KR102905799B1 (https=) |
| CN (2) | CN113631046B (https=) |
| AU (1) | AU2019376144B2 (https=) |
| BR (1) | BR112021008710A2 (https=) |
| CA (1) | CA3116021A1 (https=) |
| MX (1) | MX2021005374A (https=) |
| WO (1) | WO2020097446A1 (https=) |
| ZA (1) | ZA202102834B (https=) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6722697B2 (ja) | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| EP4162808A1 (en) * | 2018-11-08 | 2023-04-12 | DSM IP Assets B.V. | Methods of supporting gastrointestinal homeostasis |
| BR112023001738A2 (pt) * | 2020-08-12 | 2023-03-07 | Zivo Bioscience Inc | O uso de micróbios variovorax como tratamento alternativo para coccidiose |
| EP4255938A1 (en) * | 2020-12-03 | 2023-10-11 | DSM IP Assets B.V. | Oligosaccharide formulation |
| CN116528688A (zh) * | 2020-12-03 | 2023-08-01 | 帝斯曼知识产权资产管理有限公司 | 寡糖制剂 |
| WO2022175263A2 (en) * | 2021-02-16 | 2022-08-25 | Dsm Ip Assets B.V. | Methods of selectively promoting animal welfare through modulation of microbiome |
| WO2023110658A1 (en) * | 2021-12-13 | 2023-06-22 | Dsm Ip Assets B.V. | Use of oligosaccharide preparation to increase performance of animal vaccinated against coccidiosis |
| CN118804687A (zh) * | 2022-03-09 | 2024-10-18 | 帝斯曼知识产权资产管理有限公司 | 使用寡糖制备物改善蛋禽的性能 |
| EP4561588A1 (en) * | 2022-07-29 | 2025-06-04 | DSM IP Assets B.V. | Reducing necrotic enteritis effect in a bird using an oligosaccharide preparation |
| CN115944033B (zh) * | 2022-12-12 | 2025-05-02 | 中国水产科学研究院黄海水产研究所 | 5-hmf在黄条鰤促生长和提高免疫力饲料添加剂及饲料中应用 |
| CN116350642B (zh) * | 2023-02-28 | 2025-10-17 | 中南民族大学 | 1,6-脱水-β-D-葡萄糖制备用于维持结肠上皮屏障和隐窝的完整性以及抗结肠炎的药品的应用 |
| CN120897746A (zh) * | 2023-04-05 | 2025-11-04 | 帝斯曼知识产权资产管理有限公司 | 对抗呼吸系统疾病作用的寡糖制剂 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10104055A1 (de) | 2001-01-31 | 2002-08-14 | Suedzucker Ag | Verwendung von Kohlenhydraten zur Beseitigung von Darminfektionen bei Tieren |
| RU2450815C2 (ru) * | 2005-12-16 | 2012-05-20 | Н.В. Нютрисиа | Применение растворимых пищевых волокон против мышечной атрофии |
| CN102036670A (zh) * | 2007-02-01 | 2011-04-27 | 爱默思公司 | 用于减轻哺乳动物炎症和氧化应激反应的方法 |
| ES2304223B2 (es) | 2007-03-08 | 2009-05-01 | Universidad De Sevilla | Nuevos caramelos con elevado contenido en oligosacaridos prebioticos, procedimiento de preparacion y utilizacion. |
| KR101258902B1 (ko) | 2008-12-31 | 2013-05-07 | 엘지디스플레이 주식회사 | 프리즘시트, 이를 구비한 백라이트장치 및 액정표시소자 |
| GB0915315D0 (en) | 2009-09-03 | 2009-10-07 | Univ Manchester | Use of non-digestible oligosaccharides |
| RU2440121C2 (ru) * | 2009-09-23 | 2012-01-20 | Александр Владимирович Диковский | Ветеринарная фармацевтическая композиция и способ (варианты) профилактики и лечения заболеваний жкт и интоксикаций различной этиологии у животных |
| CN102091089A (zh) | 2010-11-22 | 2011-06-15 | 国家海洋局第一海洋研究所 | 一种活性牛蒡寡糖在水产养殖中的应用 |
| CA2864086C (en) | 2011-02-28 | 2018-07-10 | Midori Renewables, Inc. | Polymeric acid catalysts and uses thereof |
| EP2888044A4 (en) | 2012-08-24 | 2016-05-04 | Midori Usa Inc | POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGING CELLULOSIC MATERIALS USING SAID CATALYSTS |
| JP6722697B2 (ja) | 2015-01-26 | 2020-07-15 | カデナ・バイオ・インコーポレイテッド | 動物飼料として使用するためのオリゴ糖組成物及びその生成方法 |
| US9492473B2 (en) | 2015-01-26 | 2016-11-15 | Kaleido Biosciences, Inc. | Glycan therapeutics and related methods thereof |
| IL243707A0 (en) * | 2016-01-20 | 2016-05-01 | Galmed Res And Dev Ltd | Treatment to regulate the microbiota in the intestine |
| ES2671175B1 (es) * | 2016-11-18 | 2019-03-13 | Univ Granada | Procedimiento de preparacion de caramelos con elevado contenido en oligosacaridos prebioticos |
| US11278558B2 (en) * | 2017-03-01 | 2022-03-22 | Glycom A/S | Synthetic composition for microbiota modulation |
| CN107897512A (zh) | 2017-11-30 | 2018-04-13 | 河南普尼尔生物制药有限公司 | 一种用于改善鸡肠道健康的肠道保健剂及其制备方法 |
| EP4162808A1 (en) * | 2018-11-08 | 2023-04-12 | DSM IP Assets B.V. | Methods of supporting gastrointestinal homeostasis |
-
2019
- 2019-11-08 EP EP22211012.4A patent/EP4162808A1/en active Pending
- 2019-11-08 JP JP2021523494A patent/JP7426548B2/ja active Active
- 2019-11-08 EP EP19882420.3A patent/EP3876750A4/en active Pending
- 2019-11-08 CA CA3116021A patent/CA3116021A1/en active Pending
- 2019-11-08 KR KR1020217017142A patent/KR102905799B1/ko active Active
- 2019-11-08 KR KR1020257043137A patent/KR20260009387A/ko active Pending
- 2019-11-08 US US17/291,481 patent/US12251391B2/en active Active
- 2019-11-08 WO PCT/US2019/060443 patent/WO2020097446A1/en not_active Ceased
- 2019-11-08 MX MX2021005374A patent/MX2021005374A/es unknown
- 2019-11-08 BR BR112021008710-9A patent/BR112021008710A2/pt active Search and Examination
- 2019-11-08 CN CN201980087791.7A patent/CN113631046B/zh active Active
- 2019-11-08 CN CN202511206955.7A patent/CN121058782A/zh active Pending
- 2019-11-08 AU AU2019376144A patent/AU2019376144B2/en active Active
-
2021
- 2021-04-28 ZA ZA2021/02834A patent/ZA202102834B/en unknown
-
2023
- 2023-12-14 JP JP2023211209A patent/JP7699647B2/ja active Active
-
2024
- 2024-11-15 US US18/949,971 patent/US20250073253A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022506272A5 (https=) | ||
| Kang et al. | Eurotium cristatum, a potential probiotic fungus from Fuzhuan brick tea, alleviated obesity in mice by modulating gut microbiota | |
| Li et al. | α-D-1, 6-glucan from Castanea mollissima Blume alleviates dextran sulfate sodium-induced colitis in vivo | |
| JPWO2020097446A5 (https=) | ||
| Frendéus et al. | Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart | |
| Geerlings et al. | Pathogenesis of bacteriuria in women with diabetes mellitus | |
| Ferenczi et al. | Oligomannan prebiotic attenuates immunological, clinical and behavioral symptoms in mouse model of inflammatory bowel disease | |
| JP2022506148A5 (https=) | ||
| CN114231470A (zh) | 一株可缓解溃疡性结肠炎的嗜酸乳杆菌及其应用 | |
| CN117187096A (zh) | 用于改善肠屏障功能的大肠杆菌菌株及其应用 | |
| KR20220157975A (ko) | 사이토카인 발현을 감소시키기 위한 조성물 및 방법 | |
| CN110248646A (zh) | 包含吡非尼酮的缓释组合物用于治疗和逆转人脂肪性肝炎(nafld/nash)的药物用途 | |
| CN118745404B (zh) | 母乳来源的发酵粘液乳杆菌msjk0025在改善乳腺健康中的应用 | |
| Tsai et al. | The effect of infection order of porcine circovirus type 2 and porcine reproductive and respiratory syndrome virus on dually infected swine alveolar macrophages | |
| JP5395733B2 (ja) | ビフィズス菌属の細菌の成長を促進し、顆粒球コロニー刺激因子の放出を促進し、ｔヘルパー細胞タイプｉの分化を促進し、及び／又はｔヘルパー細胞タイプｉｉの分化を抑制するためのキバナシュスラン種・多糖類抽出物及び医薬組成物、及びその調製方法 | |
| CN113461751A (zh) | 一种高蔗果三糖含量低聚果糖及其应用 | |
| CN1446103A (zh) | 采用益生菌治疗内毒素血症及相关疾病 | |
| Ha et al. | Immunostimulation with Escherichia coli extract: prevention of recurrent urinary tract infections | |
| JP2009067742A (ja) | 抗アレルギー剤及び抗アレルギー食品 | |
| CN109419796B (zh) | 大戟因子l2在制备治疗急性肺损伤药物中的应用 | |
| US20230404969A1 (en) | Compositions and method for effective management of peritonitis | |
| CN104605160B (zh) | 一种防治母猪产后子宫内膜炎的组合物及其应用 | |
| Aamer et al. | Sepsis-induced acute kidney injury in equine: current knowledge and future perspectives | |
| Kang et al. | Eurotium cristatum, a new fungi probiotic from Fuzhuan brick tea, alleviated obesity in mice by modulating gut microbiota | |
| CN117323319B (zh) | 用于防控鸡坏死性肠炎的中药单体组合物 |